LX9211

· Lexicon Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LX9211, covering 2025-06-25 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of LX9211 in Participants With Postherpetic Neuralgia [Phase 2]